Skip to content

Top gainers Top losers Most active Market sectors Heatmap Treasury rates

Earnings calendar IPO calendar Ex-dividend calendar Economic calendar

Congress trades Insider trades Analyst upgrades & downgrades

Screener Compare Backtester

Valuation Fundamentals

Watchlist Portfolio

⌕/

Markets

Stocks Gainers Losers Most active Market sectors Heatmap Earnings calendar Congress trades Insider trades Analyst upgrades/downgrades IPO calendar Ex-dividend calendar

Tools

Screener Compare stocks Returns backtester Portfolio tracker Watchlist Embeddable widget

Metrics

Valuation Fundamentals

Popular lists

Best dividend stocks Best value stocks Largest companies Lowest P/E stocks

Collections

All lists & collections US stocks Japanese stocks Chinese stocks Hong Kong stocks South Korean stocks Taiwanese stocks Canadian stocks UK stocks European stocks Magnificent 7 AI stocks Semiconductor stocks

Compare

Compare stocks Finviz alternative Koyfin alternative TradingView alternative StockAnalysis alternative

Learn

Investing glossary Help & guide

StockMarketCapDocs Token Terms PrivacyData for information only, not investment advice.

◆

Royalty Pharma plc (RPRX) News - StockMarketCap

Stocks›Royalty Pharma plc☆

● At closeAs of Jul 2, 2026

Royalty Pharma plc

RPRX✓

HealthcareMedical - PharmaceuticalsNASDAQ

$57.77+3.57%

$24.85BMarket cap

22.75xP/E ratio

3.19MVolume (24h)

Overview Forecast Valuation Financials Technical Dividends Smart money News

Price

$57.77

$1.99 (+3.57%) · 24h

Key metrics

Market cap$24.85B+1.61%

Enterprise value$32.49B

Volume (24h)3.19M

P/E ratio (TTM)22.75x

P/S ratio (TTM)9.88x

Dividend yield1.62%

Shares outstanding430.12M

Trading range

Previous close$55.78

Day range$55.62 - $57.80

52-week range$34.08 - $57.22

Royalty Pharma plc (RPRX) operates in the Medical - Pharmaceuticals industry within the Healthcare sector, listed on NASDAQ.

Similar stocks

Eli Lilly and Company+1.57%

Johnson & Johnson+3.57%

AbbVie Inc.+3.99%

UnitedHealth Group Incorporated-0.28%

Roche Holding AG+3.89%

Merck & Co., Inc.+3.31%

Latest news